Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia

Journal of Vascular Surgery

Volumn 51, Issue 5 SUPPL., 2010, Pages 69S-75S

  Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEMODYNAMICS; HUMAN; INTERMETHOD COMPARISON; LEG AMPUTATION; LEG ISCHEMIA; LEG PROSTHESIS; LEG REVASCULARIZATION; LIMB SALVAGE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; VEIN BYPASS;

EID: 77951645389     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.001     Document Type: Article

References (21)

1. Bradbury A.W., Bell J., Lee A.J., Prescott R.J., Gillespie I., Stansby G., et al. Bypass or angioplasty for severe limb ischaemia?. A Delphi Consensus Study. Eur J Vasc Endovasc Surg 24 (2002) 411-416
2. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
3. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51 Suppl 10 (2010) 5S-17S
4. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51 Suppl 10 (2010) 18S-31S
5. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. J Vasc Surg 51 Suppl 10 (2010) 32S-42S
6. Forbes J.F., Adam D.J., Bell J., Fowkes F.G.R., Gillespie I., Raab G., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg 51 Suppl 10 (2010) 43S-51S
7. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51 Suppl 10 (2010) 52S-68S
8. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S296
9. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 suppl 1 (2007) S1-S75
10. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (1991) 445-453
11. Brass E.P., Anthony R., Dormandy J., Hiatt W.R., Jiao J., Nakanishi A., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006) 752-759
12. Conte M.S., Geraghty P.J., Bradbury A.W., Hevelone N.D., Lipsitz S.R., Moneta G.L., et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 50 (2009) 1462-1473.e1-3
13. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751 discussion 751
14. Schanzer A., Mega J., Meadows J., Samson R.H., Bandyk D.F., and Conte M.S. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 48 (2008) 1464-1471
15. Laird J.R., Zeller T., Gray B.H., Scheinert D., Vranic M., Reiser C., et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 13 (2006) 1-11
16. Giles K.A., Pomposelli F.B., Hamdan A.D., Blattman S.B., Panossian H., and Schermerhorn M.L. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 48 (2008) 128-136
17. Nguyen L.L., Moneta G.L., Conte M.S., Bandyk D.F., Clowes A.W., and Seely B.L. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 44 (2006) 977-983 discussion 983-4
18. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
19. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Namini H., and Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 42 (2005) 456-464 discussion 464-5
20. Grunkemeier G.L., Jin R., and Starr A. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Ann Thorac Surg 82 (2006) 776-780
21. Rocha-Singh K.J., Jaff M.R., Crabtree T.R., Bloch D.A., and Ansel G. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 69 (2007) 910-919